Vaccitech PLC VACC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:52 PM EST
2.23quote price arrow down-0.02 (-0.89%)
Volume
5,234
52 week range
2.08 - 12.71
Loading...
  • Open2.23
  • Day High2.26
  • Day Low2.18
  • Prev Close2.25
  • 52 Week High12.71
  • 52 Week High Date12/08/21
  • 52 Week Low2.08
  • 52 Week Low Date11/17/22

Key Stats

  • Market Cap83.18M
  • Shares Out37.30M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-79.93

KEY STATS

  • Open2.23
  • Day High2.26
  • Day Low2.18
  • Prev Close2.25
  • 52 Week High12.71
  • 52 Week High Date12/08/21
  • 52 Week Low2.08
  • 52 Week Low Date11/17/22
  • Market Cap83.18M
  • Shares Out37.30M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-79.93

RATIOS/PROFITABILITY

  • EPS (TTM)0.37
  • P/E (TTM)5.99
  • Fwd P/E (NTM)-1.19
  • EBITDA (TTM)8.794M
  • ROE (TTM)4.70%
  • Revenue (TTM)38.24M
  • Gross Margin (TTM)-
  • Net Margin (TTM)29.58%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/25/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vaccitech PLC

 

Profile

MORE
Vaccitech plc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The Company uses its platform to develop product candidates that target immune responses against pathogens and tumor cells. The Company has a pipeline of both clinical and preclinical stage therapeutic and prophylactic programs. Its therapeutic programs...
Robin Wright
Non-Executive Independent Chairman of the Board
William Enright
Chief Executive Officer, Director
Gemma Brown
Chief Financial Officer
Address
The Schrdinger Building
Heatley Road, The Oxford Science Park
Didcot
OX11 0DF
United Kingdom